Sort
82,697 grants matching “vaccine development”
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$929,964Andrew Redd · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Non-Human Primate Core
$929,847Norman L Letvin · Duke University · U19 · FY2009 · AI
Design and testing of germline-targeting and boosting immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV
$929,812William R Schief · Scripps Research Institute, The · R56 · FY2018 · AI
HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals
$929,677Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Evaluation fo Live Attenuated B. Melitensis Vaccines in Nonhuman Primates
$929,571Thomas A Ficht · University Of Texas Med Br Galveston · U54 · FY2013 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$929,563William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
SEQUENCE AND POLYMORPHISM OF RHESUS MACAQUE MHC
$929,514Fred Hutchinson Cancer Research Center · R24 · FY2005 · RR
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$929,501Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$929,248Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2009 · MH
Non-human Primate (NHP Core)
$929,192James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$929,155Michael R. Farzan · Scripps Florida · R37 · FY2016 · AI
Diabetes Evaluation in Washington (DEW-IT) Clinical Cen*
$929,041William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2006 · DK
Development of Nipah virus mRNA vaccine
$929,036Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
HPV, HIV and Oral Microbiota Interplay in Nigerian Youth (HOMINY)
$929,004Modupe Coker · Rutgers Biomedical And Health Sciences · R01 · FY2023 · DE
Vaccines and Therapeutics for Anthrax
$928,890Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants
$928,696Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2016 · AI
HIV neutralization and mechanisms of cellular entry
$928,538Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Targeting PD-1 Pathway for Functional Cure of AIDS
$928,498Rama Rao Amara · Emory University · R01 · FY2024 · AI
A Cytomegalovirus-based therapeutic vaccine against oncogenic human papillomaviruses
$928,329Eric Bruening · Tomegavax, Inc. · R44 · FY2017 · CA
Inhibition of COVID-19 associated acute fibrin deposition in lung
$928,309Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
$928,224Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES
$928,138John Morrey · Utah State University · N01 · FY2020 · DA
Genital Anaerobes, Inflammation and HIV Risk; Rakai
$927,881Ronald H Gray · Johns Hopkins University · R01 · FY2010 · AI
Induction of protective t-cell responses to HIV-1
$927,872Andrew James McMichael · Duke University · UM1 · FY2015 · AI
Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND
$927,669Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2018 · AG